Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04101526 · ClinicalTrials.gov registry record · NA
Developing and Testing a Spanish-Language Intervention to Reduce Cancer-Related Sleep Disturbance
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04101526: Completed NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT04101526 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04101526, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to learn about how to provide treatment to cancer survivors who have difficulty sleeping.
Primary Outcome
The study will be deemed acceptable if ≥ 50% of eligible cancer survivors who are approached agree to participate. Recruitment rate will be measured by percentage of patients enrolled.
Interventions
- BEHAVIORAL Spanish-language Cognitive-Behavioral Therapy for Insomnia (CBT-I) delivered via videoconference
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-08-15 |
| Est. Completion | 2021-04-09 |
| Phase | NA |
What the finished NCT04101526 record still lists
NCT04101526 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Spanish-language Cognitive-Behavioral Therapy for Insomnia (CBT-I) delivered via videoconference is the first listed.
NCT04101526 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04101526 about?
NCT04101526 is a clinical study titled "Developing and Testing a Spanish-Language Intervention to Reduce Cancer-Related Sleep Disturbance". The purpose of this study is to learn about how to provide treatment to cancer survivors who have difficulty sleeping.
What is the current status of trial NCT04101526?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2019-08-15. Estimated completion is 2021-04-09.
What interventions are being tested in trial NCT04101526?
The interventions under investigation include: Spanish-language Cognitive-Behavioral Therapy for Insomnia (CBT-I) delivered via videoconference (BEHAVIORAL).
Who is sponsoring clinical trial NCT04101526?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04101526's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI